This compound is a brominated quinolinone derivative used as a pharmaceutical intermediate. It features an amide group, an aromatic ring, an ether linkage, and a halogen substituent, with moderate lipophilicity and a polar surface area of 38.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 129722-34-5
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
pharmaceutical impurity
7-(4-chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone
pharmaceutical impurity reference standard
2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile
pharmaceutical intermediate
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile
Pharmaceutical intermediate for darolutamide
3-acetyl-1H-pyrazole-5-carboxylic acid
pharmaceutical intermediate
Di-tert-butyl (2-oxopropane-1,3-diyl)dicarbamate
synthetic intermediate for midazolam impurities
7-Methoxy-3,4-dihydroquinolin-2(1H)-one
Pharmaceutical intermediate
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone
pharmaceutical intermediate
7-(4-bromobutoxy)-3,4-dihydro-1H-quinolin-2-one
URHLNHVYMNBPEO-UHFFFAOYSA-N
C1CC(=O)NC2=C1C=CC(=C2)OCCCCBr